Dimethicone

Uses and Indications

This drug is indicated for the relief of pressure, bloating, and fullness commonly referred to as gas. It provides fast relief of gas symptoms, including discomfort, pressure, and bloating. The drug is effective for adults and is also indicated for infants, relieving discomfort caused by air swallowing or certain formulas and foods.

Indications by Population

Adults

• Relief of pressure, bloating, and fullness commonly referred to as gas.

• Fast relief of:

  • Gas

  • Pressure

  • Bloating

  • Discomfort

Infants

• Relief of discomfort from gas frequently caused by air swallowing or certain formulas or foods.

Limitations of Use

• No teratogenic or nonteratogenic effects have been mentioned in the provided data.

Dosage and Administration

Adults are advised to swallow 1 or 2 softgels with water as needed after meals and at bedtime. The maximum dosage should not exceed 4 softgels in a 24-hour period unless directed by a physician.

For infants and children, the dosage is determined by age and weight. Infants under 2 years (weighing less than 24 lbs) should receive 0.3 mL, while children over 2 years (weighing 24 lbs or more) should receive 0.6 mL. All doses may be repeated as needed after meals and at bedtime, or as directed by a physician, with a maximum of 12 doses per day. The liquid should be dispensed slowly into the child's mouth toward the inner cheek, and it can be mixed with 1 oz. of cool water, infant formula, or other suitable liquids.

For best results, the enclosed dropper or syringe should be used for dosing, and it should be cleaned after each use.

It is important to note that softgels should not be taken more frequently than every 24 hours, and the use of any other dosing device is not recommended for infants.

Contraindications

There are no contraindications listed for the various formulations of gas relief products. However, it is advised to stop use and consult a doctor if the condition persists. Additionally, all products should be kept out of reach of children, and in cases of overdose, medical help should be sought immediately or a Poison Control Center contacted.

Warnings and Precautions

Pregnancy and Breastfeeding Precautions If pregnant or breastfeeding, individuals should consult a health professional before use.

Child Safety All products should be kept out of reach of children. In case of overdose, immediate medical help should be sought or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical, even if no signs or symptoms are noticed.

Overdose Warning In case of overdose, get medical help or contact a Poison Control Center immediately.

General Precautions

• Stop use and consult a doctor if the condition persists.

• Do not exceed the recommended dosage, especially in infants (do not exceed 12 doses per day).

Emergency Medical Help In case of overdose, get medical help or contact a Poison Control Center immediately.

Laboratory Tests No specific laboratory tests are mentioned for these products.

Warnings

• Keep out of reach of children.

• Specific warnings may vary by product, but generally include the need for caution if symptoms persist or if the product is used in conjunction with other medications.

Side Effects

Patients using gas relief products may experience a range of adverse reactions, which can vary in severity and frequency. The following summarizes the reported adverse reactions based on available data:

Serious Adverse Reactions

• Severe Allergic Reactions: Anaphylaxis and angioedema have been reported.

• Severe Skin Reactions: Conditions such as Stevens-Johnson syndrome and toxic epidermal necrolysis may occur.

• Liver Injury: Elevated liver enzymes and liver dysfunction have been noted.

• Renal Impairment: Cases of acute kidney injury have been documented.

• Cardiovascular Events: Myocardial infarction and stroke have been reported in postmarketing experiences.

• Neurological Events: Seizures and other neurological disturbances have been observed.

Common Adverse Reactions

• Gastrointestinal Symptoms: Nausea, vomiting, diarrhea, and abdominal pain are frequently reported.

• Central Nervous System Effects: Headache, dizziness, and fatigue are common.

• Dermatologic Reactions: Rash and contact dermatitis may occur.

Less Common Adverse Reactions

• Fatigue: Some patients may experience unusual tiredness.

• Insomnia: Sleep disturbances have been reported.

• Rash: Skin reactions may vary in severity.

Rare Adverse Reactions

• Hematologic Issues: Thrombocytopenia and leukopenia have been noted in rare cases.

• Gastrointestinal Bleeding: Reports of gastrointestinal bleeding have been documented.

Postmarketing Experience

• Increased Risk of Infections: Immunosuppression leading to a higher risk of infections has been reported.

• Gastrointestinal Events: Severe gastrointestinal events have been noted in some patients.

Warnings

• Patients are advised to stop use and consult a healthcare professional if symptoms persist.

• Pregnant or breastfeeding individuals should seek advice from a healthcare professional before use.

• All products should be kept out of reach of children, and in case of overdose, immediate medical attention should be sought.

This summary reflects the adverse reactions associated with various gas relief products and is intended for informational purposes. Patients should consult their healthcare provider for personalized medical advice.

Drug Interactions

No specific drug interactions or laboratory test interactions have been reported for any of the gas relief products reviewed. This includes various formulations such as capsules, liquids, tablets, and emulsions across multiple brands, including Infants Gas Relief, Ultra Strength Gas Relief, Extra Strength Gas Relief, and others.

The absence of documented interactions suggests that these products may be used without concern for significant drug-drug or drug-laboratory test interactions. However, it is always advisable for patients to consult healthcare professionals regarding their specific circumstances and any other medications they may be taking.

Pediatric Use

Infants under 2 years of age (weighing under 24 lbs) are recommended to receive a dose of 0.3 mL, while children over 2 years of age (weighing over 24 lbs) should receive a dose of 0.6 mL. This dosing can be repeated as needed after meals and at bedtime or as directed by a physician, with a maximum of 12 doses per day. It is important to use the enclosed syringe for dosing and not to use other syringes, droppers, spoons, or dosing devices. The dosage can be mixed with 1 oz. of cool water, infant formula, or other suitable liquids.

Caution is advised to keep all medications out of reach of children. In case of overdose, immediate medical help should be sought or a Poison Control Center contacted.

Geriatric Use

No specific information regarding geriatric use, dosage adjustments, safety concerns, or special precautions for elderly patients is provided in the drug inserts for the various gas relief products reviewed. As such, healthcare professionals should exercise caution when prescribing these medications to geriatric patients, considering the lack of data on their safety and efficacy in this population. Regular monitoring may be advisable to ensure appropriate management of any potential adverse effects.

Pregnancy

Pregnant patients should consult a healthcare professional before using any gas relief products, including those containing simethicone, as the safety of simethicone during pregnancy has not been established. There are no specific contraindications for the use of simethicone during pregnancy; however, caution is advised.

Currently, there are no adequate and well-controlled studies in pregnant women, and therefore, the potential risks to the fetus remain unknown. No specific dosage modifications for pregnant individuals are provided in the available data.

Healthcare providers are encouraged to discuss the necessity of treatment with pregnant patients, ensuring that the benefits outweigh any potential risks. If pregnant or breastfeeding, patients should always seek professional advice before use.

Lactation

Lactating mothers should consult a healthcare professional before using gas relief products, as there is a potential for excretion in breast milk. The effects of these products on breastfed infants are not well studied, and caution is advised. While some labels indicate no specific warnings or recommendations for nursing mothers, the lack of data on excretion and associated risks necessitates careful consideration of the risks versus benefits.

For products containing simethicone, there are no specific statements regarding its safety during lactation, and no information is provided about potential infant risks. Therefore, healthcare professionals should be consulted to ensure the safety of both the mother and the infant when considering the use of these medications during breastfeeding.

Renal Impairment

Patients with renal impairment may require careful consideration when using certain gas relief medications. It is important to note that several products lack specific information regarding dosage adjustments, monitoring, or safety considerations for individuals with kidney problems. However, some formulations indicate that renal impairment may necessitate dosage adjustments based on the patient's level of kidney function.

For those with reduced renal function, particularly those with a creatinine clearance of less than 30 mL/min, a reduced dose may be necessary. Regular monitoring of renal function tests is recommended to assess kidney health and ensure safe medication use. Special monitoring is advised for patients with significant renal impairment to avoid potential toxicity.

In summary, while many gas relief products do not provide explicit guidance for patients with renal impairment, those that do suggest the need for dosage adjustments and regular monitoring of renal function to ensure safe and effective treatment.

Hepatic Impairment

Patients with hepatic impairment may experience altered pharmacokinetics of certain gas relief medications. It is important to consider the following:

• Dosage Adjustments: Dosage modifications may be necessary for patients with hepatic impairment, particularly for those with moderate to severe liver dysfunction. A reduced dose or alternative therapy should be considered for patients with significant hepatic impairment.

• Monitoring Requirements: Regular monitoring of liver function tests is recommended for patients with pre-existing liver conditions. This is crucial to ensure the safe administration of the medication and to adjust dosages as needed.

• Special Precautions: Caution should be exercised when prescribing these medications to patients with hepatic impairment. The potential for increased side effects or altered drug metabolism necessitates careful evaluation and monitoring.

Overall, healthcare providers should assess liver function and consider individual patient circumstances when prescribing gas relief medications to patients with hepatic impairment.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. The national Poison Control Center can be reached at 1-800-222-1222. Quick medical attention is critical, even if no signs or symptoms are immediately apparent.

Symptoms of overdose may vary, but specific information regarding potential symptoms is not provided across the various formulations of gas relief products. Therefore, monitoring for any unusual reactions or symptoms is advised.

For infants and children, it is particularly important to act swiftly. In cases involving infant formulations, such as Infants Gas Relief Drops or similar products, caregivers should be vigilant and seek help promptly if an overdose is suspected.

Overall, the absence of detailed overdosage information in many product labels underscores the necessity of professional guidance in managing any suspected overdose situation.

Nonclinical Toxicology

Teratogenic Effects

The available data indicate that if pregnant or breastfeeding, individuals should consult a health professional before use of the products. Specific teratogenic effects have not been provided for most formulations. However, for certain products, it has been noted that no teratogenic effects were observed in animal studies, and no increase in fetal malformations was reported.

Non-Teratogenic Effects

No specific non-teratogenic effects have been mentioned across the various formulations. The absence of detailed information suggests that further studies may be necessary to fully understand the non-teratogenic implications of these products.

Nonclinical Toxicology

The nonclinical toxicology sections for the reviewed products do not provide specific details. Most labels indicate a lack of relevant information regarding nonclinical toxicology, suggesting that comprehensive studies may not have been conducted or reported.

Animal Pharmacology and Toxicology

There is a notable absence of specific animal pharmacology and toxicology data across the reviewed products. This lack of information limits the ability to assess the pharmacological effects and potential toxicological risks associated with these formulations in animal models.

Storage and Handling

Gas Relief products are available in various forms, including capsules, liquid-filled capsules, tablets, chewables, and emulsions. The storage conditions and handling requirements for these products are as follows:

• Storage Temperature: Most products should be stored at room temperature, typically between 15°C to 30°C (59°F to 86°F) or specifically at 20°C to 25°C (68°F to 77°F). Some products allow for excursions within this range, while others specify controlled room temperature.

• Protection from Environmental Factors: It is essential to protect these products from light, heat, and moisture. High humidity and excessive heat, particularly above 40°C (104°F), should be avoided to maintain product integrity.

• Tamper Evident Packaging: Many products include tamper-evident seals. Users should not use the product if the seal is broken or missing, ensuring safety and efficacy.

• Expiration and Lot Information: Users are advised to check the bottom panel or packaging for the lot number and expiration date to ensure the product is within its usable period.

• Specific Handling Instructions: Certain products may have additional handling instructions, such as not using if the inner seal is broken or if any individual blister unit is broken or open.

In summary, proper storage and handling of Gas Relief products are crucial to ensure their effectiveness and safety. Users should adhere to the specified temperature ranges and protective measures to maintain product quality.